Quantitative Proteomics Analysis of Vitreous Humor from Diabetic Retinopathy Patients

Journal of Proteome Research

Volumn 14, Issue 12, 2015, Pages 5131-5143

  Loukovaara, Sirpa ^a   Nurkkala, Helka ^b   Tamene, Fitsum ^b   Gucciardo, Erika ^c   Liu, Xiaonan ^b   Repo, Pauliina ^c   Lehti, Kaisa ^c   Varjosalo, Markku ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

apolipoproteins; coagulation cascade; complement system; diabetic retinopathy; label free quantification; quantitative proteomics; vitreous humor

Indexed keywords

BEVACIZUMAB; PROTEOME; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE COURSE; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; VITREOUS BODY; ANTAGONISTS AND INHIBITORS; METABOLISM; PATHOLOGY; PROCEDURES;

BEVACIZUMAB; CHROMATOGRAPHY, LIQUID; DIABETIC RETINOPATHY; HUMANS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 84948978308     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00900     Document Type: Article

References (82)

1. Cunha-Vaz, J.; Ribeiro, L.; Lobo, C. Phenotypes and biomarkers of diabetic retinopathy Prog. Retinal Eye Res. 2014, 41, 90-111 10.1016/j.preteyeres.2014.03.003
2. Early Treatment Diabetic Retinopathy Study Research Group Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10 Ophthalmology 1991, 98, 786-806 10.1016/S0161-6420(13)38012-9
3. Lamoureux, E. L.; Wong, T. Y. Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials Diabetes Care 2011, 34, 1066-1067 10.2337/dc11-0225
4. Loukovaara, S.; Gucciardo, E.; Repo, P.; Vihinen, H.; Lohi, J.; Jokitalo, E.; Salven, P.; Lehti, K. Indications of lymphatic endothelial differentiation and endothelial progenitor cell activation in the pathology of proliferative diabetic retinopathy Acta Ophthalmol. 2015, 93, 512-523 10.1111/aos.12741
5. IDF Diabetes Atlas, 6 th ed.; International Diabetes Federation: Brussels, Belgium, 2013. http://www.idf.org/diabetesatlas (accessed August 22, 2014).
6. Brand, C. S. Management of retinal vascular diseases: a patient-centric approach Eye (London, U. K.) 2012, 26 (Suppl 2) S1-16 10.1038/eye.2012.32
7. Mohamed, Q.; Gillies, M. C.; Wong, T. Y. Management of diabetic retinopathy: a systematic review JAMA 2007, 298, 902-916 10.1001/jama.298.8.902
8. Simo, R.; Hernandez, C. Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy Diabetologia 2008, 51, 1574-1580 10.1007/s00125-008-0989-9
9. Robinson, R.; Barathi, V. A.; Chaurasia, S. S.; Wong, T. Y.; Kern, T. S. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals Dis. Models & Mech. 2012, 5, 444-456 10.1242/dmm.009597
10. Gao, B. B.; Chen, X.; Timothy, N.; Aiello, L. P.; Feener, E. P. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy J. Proteome Res. 2008, 7, 2516-2525 10.1021/pr800112g
11. Kim, T.; Kim, S. J.; Kim, K.; Kang, U. B.; Lee, C.; Park, K. S.; Yu, H. G.; Kim, Y. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients Proteomics 2007, 7, 4203-4215 10.1002/pmic.200700745
12. Wang, H.; Feng, L.; Hu, J.; Xie, C.; Wang, F. Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry Exp. Eye Res. 2013, 108, 110-119 10.1016/j.exer.2012.11.023
13. Murthy, K. R.; Goel, R.; Subbannayya, Y.; Jacob, H. K.; Murthy, P. R.; Manda, S. S.; Patil, A. H.; Sharma, R.; Sahasrabuddhe, N. A.; Parashar, A.; Nair, B. G.; Krishna, V.; Prasad, T. K.; Gowda, H.; Pandey, A. Proteomic analysis of human vitreous humor Clin Proteomics 2014, 11, 29 10.1186/1559-0275-11-29
14. Gisladottir, S.; Loftsson, T.; Stefansson, E. Diffusion characteristics of vitreous humour and saline solution follow the Stokes Einstein equation Graefe's Arch. Clin. Exp. Ophthalmol. 2009, 247, 1677-1684 10.1007/s00417-009-1141-3
15. Aretz, S.; Krohne, T. U.; Kammerer, K.; Warnken, U.; Hotz-Wagenblatt, A.; Bergmann, M.; Stanzel, B. V.; Kempf, T.; Holz, F. G.; Schnolzer, M.; Kopitz, J. In-depth mass spectrometric mapping of the human vitreous proteome Proteome Sci. 2013, 11, 22 10.1186/1477-5956-11-22
16. Theocharis, A. Occurrence and structural characterization of versican-like proteoglycan in human vitreous Biochimie 2002, 84, 1235-1241 10.1016/S0300-9084(02)00015-9
17. Angi, M.; Kalirai, H.; Coupland, S. E.; Damato, B. E.; Semeraro, F.; Romano, M. R. Proteomic analyses of the vitreous humour Mediators Inflammation 2012, 2012, 148039 10.1155/2012/148039
18. Bennett, K. L.; Funk, M.; Tschernutter, M.; Breitwieser, F. P.; Planyavsky, M.; Mohien, C. U.; Muller, A.; Trajanoski, Z.; Colinge, J.; Superti-Furga, G.; Schmidt-Erfurth, U. Proteomic analysis of human cataract aqueous humour: Comparison of one-dimensional gel LCMS with two-dimensional LCMS of unlabelled and iTRAQ(R)-labelled specimens J. Proteomics 2011, 74, 151-166 10.1016/j.jprot.2010.10.002
19. Pollreisz, A.; Funk, M.; Breitwieser, F. P.; Parapatics, K.; Sacu, S.; Georgopoulos, M.; Dunavoelgyi, R.; Zlabinger, G. J.; Colinge, J.; Bennett, K. L.; Schmidt-Erfurth, U. Quantitative proteomics of aqueous and vitreous fluid from patients with idiopathic epiretinal membranes Exp. Eye Res. 2013, 108, 48-58 10.1016/j.exer.2012.11.010
20. Yu, J.; Peng, R.; Chen, H.; Cui, C.; Ba, J. Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis Invest. Ophthalmol. Visual Sci. 2012, 53, 8146-8153 10.1167/iovs.12-10079
21. Gao, B. B.; Clermont, A.; Rook, S.; Fonda, S. J.; Srinivasan, V. J.; Wojtkowski, M.; Fujimoto, J. G.; Avery, R. L.; Arrigg, P. G.; Bursell, S. E.; Aiello, L. P.; Feener, E. P. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation Nat. Med. 2007, 13, 181-188 10.1038/nm1534
22. Merchant, M. L.; Klein, J. B. Proteomics and diabetic retinopathy Clin Lab Med. 2009, 29, 139-149 10.1016/j.cll.2009.01.008
23. Loukovaara, S.; Robciuc, A.; Holopainen, J. M.; Lehti, K.; Pessi, T.; Liinamaa, J.; Kukkonen, K. T.; Jauhiainen, M.; Koli, K.; Keski-Oja, J.; Immonen, I. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFbeta1 in diabetic eyes undergoing vitrectomy Acta Ophthalmol. 2013, 91, 531-539 10.1111/j.1755-3768.2012.02473.x
24. Bloemendal, H.; de Jong, W.; Jaenicke, R.; Lubsen, N. H.; Slingsby, C.; Tardieu, A. Ageing and vision: structure, stability and function of lens crystallins Prog. Biophys. Mol. Biol. 2004, 86, 407-485 10.1016/j.pbiomolbio.2003.11.012
25. Huang, D. W.; Sherman, B. T.; Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 2008, 4, 44-57 10.1038/nprot.2008.211
26. Huang, D. W.; Sherman, B. T.; Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists Nucleic Acids Res. 2009, 37, 1-13 10.1093/nar/gkn923
27. Kall, L.; Krogh, A.; Sonnhammer, E. L. A combined transmembrane topology and signal peptide prediction method J. Mol. Biol. 2004, 338, 1027-1036 10.1016/j.jmb.2004.03.016
28. Ivankov, D. N.; Bogatyreva, N. S.; Honigschmid, P.; Dislich, B.; Hogl, S.; Kuhn, P. H.; Frishman, D.; Lichtenthaler, S. F. QARIP: a web server for quantitative proteomic analysis of regulated intramembrane proteolysis Nucleic Acids Res. 2013, 41, W459-464 10.1093/nar/gkt436
29. Cowley, M. J.; Pinese, M.; Kassahn, K. S.; Waddell, N.; Pearson, J. V.; Grimmond, S. M.; Biankin, A. V.; Hautaniemi, S.; Wu, J. PINA v2.0: mining interactome modules Nucleic Acids Res. 2012, 40, D862-865 10.1093/nar/gkr967
30. Schneider, C. A.; Rasband, W. S.; Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis Nat. Methods 2012, 9, 671-675 10.1038/nmeth.2089
31. Eng, J. K.; McCormack, A. L.; Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database J. Am. Soc. Mass Spectrom. 1994, 5, 976-989 10.1016/1044-0305(94)80016-2
32. Brown, M. S.; Ye, J.; Rawson, R. B.; Goldstein, J. L. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans Cell 2000, 100, 391-398 10.1016/S0092-8674(00)80675-3
33. Reiss, K.; Saftig, P. The ©a disintegrin and metalloprotease© (ADAM) family of sheddases: physiological and cellular functions Semin. Cell Dev. Biol. 2009, 20, 126-137 10.1016/j.semcdb.2008.11.002
34. Carlson, E. C.; Lin, M.; Liu, C. Y.; Kao, W. W.; Perez, V. L.; Pearlman, E. Keratocan and lumican regulate neutrophil infiltration and corneal clarity in lipopolysaccharide-induced keratitis by direct interaction with CXCL1 J. Biol. Chem. 2007, 282, 35502-35509 10.1074/jbc.M705823200
35. Carlson, E. C.; Wang, I. J.; Liu, C. Y.; Brannan, P.; Kao, C. W.; Kao, W. W. Altered KSPG expression by keratocytes following corneal injury Mol. Vis 2003, 9, 615-623
36. Chakravarti, S.; Magnuson, T.; Lass, J. H.; Jepsen, K. J.; LaMantia, C.; Carroll, H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican J. Cell Biol. 1998, 141, 1277-1286 10.1083/jcb.141.5.1277
37. Rada, J. A.; Cornuet, P. K.; Hassell, J. R. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins Exp. Eye Res. 1993, 56, 635-648 10.1006/exer.1993.1081
38. Wu, F.; Vij, N.; Roberts, L.; Lopez-Briones, S.; Joyce, S.; Chakravarti, S. A novel role of the lumican core protein in bacterial lipopolysaccharide-induced innate immune response J. Biol. Chem. 2007, 282, 26409-26417 10.1074/jbc.M702402200
39. Carlson, E. C.; Sun, Y.; Auletta, J.; Kao, W. W.; Liu, C. Y.; Perez, V. L.; Pearlman, E. Regulation of corneal inflammation by neutrophil-dependent cleavage of keratan sulfate proteoglycans as a model for breakdown of the chemokine gradient J. Leukocyte Biol. 2010, 88, 517-522 10.1189/jlb.0310134
40. Gray, R. S.; James, K.; Merriman, J.; Starkey, I. R.; Elton, R. A.; Clarke, B. F.; Duncan, L. J. Alpha 2-macroglobulin and proliferative retinopathy in type 1 diabetes Horm. Metab. Res. 1982, 14, 389-392 10.1055/s-2007-1019026
41. James, K.; Merriman, J.; Gray, R. S.; Duncan, L. J.; Herd, R. Serum alpha 2-macroglobulin levels in diabetes J. Clin. Pathol. 1980, 33, 163-166 10.1136/jcp.33.2.163
42. Takada, T.; Kodera, Y.; Matsubara, M.; Kawashima, Y.; Maeda, T.; Fujita, Y.; Shichiri, M. Serum monomeric alpha2-macroglobulin as a clinical biomarker in diabetes Atherosclerosis 2013, 228, 270-276 10.1016/j.atherosclerosis.2013.02.035
43. Ouchi, M.; West, K.; Crabb, J. W.; Kinoshita, S.; Kamei, M. Proteomic analysis of vitreous from diabetic macular edema Exp. Eye Res. 2005, 81, 176-182 10.1016/j.exer.2005.01.020
44. Grattagliano, I.; Vendemiale, G.; Boscia, F.; Micelli-Ferrari, T.; Cardia, L.; Altomare, E. Oxidative retinal products and ocular damages in diabetic patients Free Radical Biol. Med. 1998, 25, 369-372 10.1016/S0891-5849(98)00059-8
45. Loukovaara, S.; Koivunen, P.; Ingles, M.; Escobar, J.; Vento, M.; Andersson, S. Elevated protein carbonyl and HIF-1alpha levels in eyes with proliferative diabetic retinopathy Acta Ophthalmol. 2014, 92, 323-327 10.1111/aos.12186
46. Tsilibary, E. C. Microvascular basement membranes in diabetes mellitus J. Pathol. 2003, 200, 537-546 10.1002/path.1439
47. Medzhitov, R. Origin and physiological roles of inflammation Nature 2008, 454, 428-435 10.1038/nature07201
48. Simo-Servat, O.; Hernandez, C.; Simo, R. Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy Mediators Inflammation 2012, 2012, 872978 10.1155/2012/872978
49. Aiello, L. P.; Gardner, T. W.; King, G. L.; Blankenship, G.; Cavallerano, J. D.; Ferris, F. L., 3rd; Klein, R. Diabetic retinopathy Diabetes Care 1998, 21, 143-156 10.2337/diacare.21.1.143
50. Kvanta, A. Ocular angiogenesis: the role of growth factors Acta Ophthalmol. Scand. 2006, 84, 282-288 10.1111/j.1600-0420.2006.00659.x
51. Agarwal, A.; Sarwar, S.; Sepah, Y. J.; Nguyen, Q. D. What have we learnt about the management of diabetic macular edema in the antivascular endothelial growth factor and corticosteroid era? Curr. Opin Ophthalmol 2015, 26, 177-183 10.1097/ICU.0000000000000152
52. Chen, Y.; Hu, Y.; Zhou, T.; Zhou, K. K.; Mott, R.; Wu, M.; Boulton, M.; Lyons, T. J.; Gao, G.; Ma, J. X. Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models Am. J. Pathol. 2009, 175, 2676-2685 10.2353/ajpath.2009.080945
53. Surace, E. M.; Balaggan, K. S.; Tessitore, A.; Mussolino, C.; Cotugno, G.; Bonetti, C.; Vitale, A.; Ali, R. R.; Auricchio, A. Inhibition of ocular neovascularization by hedgehog blockade Mol. Ther. 2006, 13, 573-579 10.1016/j.ymthe.2005.10.010
54. Ghattas, A.; Lip, P. L.; Lip, G. Y. Renin-angiotensin blockade in diabetic retinopathy Int. J. Clin Pract 2011, 65, 113-116 10.1111/j.1742-1241.2010.02592.x
55. Roy, S.; Bae, E.; Amin, S.; Kim, D. Extracellular matrix, gap junctions, and retinal vascular homeostasis in diabetic retinopathy Exp. Eye Res. 2015, 133, 58-68 10.1016/j.exer.2014.08.011
56. Suzuki, K.; Okuno, T.; Yamamoto, M.; Pasterkamp, R. J.; Takegahara, N.; Takamatsu, H.; Kitao, T.; Takagi, J.; Rennert, P. D.; Kolodkin, A. L.; Kumanogoh, A.; Kikutani, H. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin Nature 2007, 446, 680-684 10.1038/nature05652
57. Grigsby, J. G.; Cardona, S. M.; Pouw, C. E.; Muniz, A.; Mendiola, A. S.; Tsin, A. T.; Allen, D. M.; Cardona, A. E. The role of microglia in diabetic retinopathy J. Ophthalmol. 2014, 2014, 705783 10.1155/2014/705783
58. O'Brien, M. The reciprocal relationship between inflammation and coagulation Top Companion Anim Med. 2012, 27, 46-52 10.1053/j.tcam.2012.06.003
59. Norris, L. A. Blood coagulation Best Pract Res. Clin Obstet Gynaecol 2003, 17, 369-383 10.1016/S1521-6934(03)00014-2
60. de Witt, S. M.; Verdoold, R.; Cosemans, J. M.; Heemskerk, J. W. Insights into platelet-based control of coagulation Thromb. Res. 2014, 133 (Suppl 2) S139-148 10.1016/S0049-3848(14)50024-2
61. Asakawa, H.; Tokunaga, K.; Kawakami, F. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy J. Diabetes Complications 2000, 14, 121-126 10.1016/S1056-8727(00)00075-1
62. Lu, C. H.; Lin, S. T.; Chou, H. C.; Lee, Y. R.; Chan, H. L. Proteomic analysis of retinopathy-related plasma biomarkers in diabetic patients Arch. Biochem. Biophys. 2013, 529, 146-156 10.1016/j.abb.2012.11.004
63. Mackay, I. R.; Rosen, F. S.; Walport, M. J. Complement. First of two parts N. Engl. J. Med. 2001, 344, 1058-1066 10.1056/NEJM200104053441406
64. Jha, P.; Bora, P. S.; Bora, N. S. The role of complement system in ocular diseases including uveitis and macular degeneration Mol. Immunol. 2007, 44, 3901-3908 10.1016/j.molimm.2007.06.145
65. Fujita, T.; Hemmi, S.; Kajiwara, M.; Yabuki, M.; Fuke, Y.; Satomura, A.; Soma, M. Complement-mediated chronic inflammation is associated with diabetic microvascular complication Diabetes/Metab. Res. Rev. 2013, 29, 220-226 10.1002/dmrr.2380
66. Campbell, D. J. The kallikrein-kinin system in humans Clin. Exp. Pharmacol. Physiol. 2001, 28, 1060-1065 10.1046/j.1440-1681.2001.03564.x
67. Campbell, D. J. The renin-angiotensin and the kallikrein-kinin systems Int. J. Biochem. Cell Biol. 2003, 35, 784-791 10.1016/S1357-2725(02)00262-5
68. Tom, B.; Dendorfer, A.; Jan Danser, A. H. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact? Int. J. Biochem. Cell Biol. 2003, 35, 792-801 10.1016/S1357-2725(02)00273-X
69. Liu, J.; Clermont, A. C.; Gao, B. B.; Feener, E. P. Intraocular hemorrhage causes retinal vascular dysfunction via plasma kallikrein Invest. Ophthalmol. Visual Sci. 2013, 54, 1086-1094 10.1167/iovs.12-10537
70. Lyons, T. J. et al. Diabetic Retinopathy and Serum Lipoprotein Subclasses in the DCCT/EDIC Cohort Invest. Ophthalmol. Visual Sci. 2004, 45, 910-918 10.1167/iovs.02-0648
71. Simo, R.; Higuera, M.; Garcia-Ramirez, M.; Canals, F.; Garcia-Arumi, J.; Hernandez, C. Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients Arch. Ophthalmol. 2008, 126, 1076-1081 10.1001/archopht.126.8.1076
72. Sasongko, M. B.; Wong, T. Y.; Nguyen, T. T.; Kawasaki, R.; Jenkins, A.; Shaw, J.; Wang, J. J. Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids Diabetes Care 2011, 34, 474-479 10.2337/dc10-0793
73. Silva, P. S.; Sun, J. K.; Aiello, L. P. Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy Semin Ophthalmol 2009, 24, 93-99 10.1080/08820530902800355
74. Gunther, J.; Ip, M. Intravitreal steroid versus macular laser for treatment of diabetic macular edema Curr. Diabetes Rep. 2009, 9, 272-276 10.1007/s11892-009-0042-5
75. Colhoun, H. M.; Betteridge, D. J.; Durrington, P. N.; Hitman, G. A.; Neil, H. A.; Livingstone, S. J.; Thomason, M. J.; Mackness, M. I.; Charlton-Menys, V.; Fuller, J. H. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Lancet 2004, 364, 685-696 10.1016/S0140-6736(04)16895-5
76. Cusick, M.; Chew, E. Y.; Chan, C. C.; Kruth, H. S.; Murphy, R. P.; Ferris, F. L., 3rd. Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels Ophthalmology 2003, 110, 2126-2133 10.1016/j.ophtha.2003.01.001
77. Danesh, F. R.; Kanwar, Y. S. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy FASEB J. 2004, 18, 805-815 10.1096/fj.03-0839rev
78. Baranano, D. E.; Kim, S. J.; Edelhauser, H. F.; Durairaj, C.; Kompella, U. B.; Handa, J. T. Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation Br. J. Ophthalmol. 2009, 93, 1387-1390 10.1136/bjo.2009.157297
79. Kim, S. J.; Flach, A. J.; Jampol, L. M. Nonsteroidal anti-inflammatory drugs in ophthalmology Surv. Ophthalmol. 2010, 55, 108-133 10.1016/j.survophthal.2009.07.005
80. Soheilian, M.; Karimi, S.; Ramezani, A.; Peyman, G. A. Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies Retina 2010, 30, 509-515 10.1097/IAE.0b013e3181bdfa43
81. Yehoshua, Z.; de Amorim Garcia Filho, C. A.; Nunes, R. P.; Gregori, G.; Penha, F. M.; Moshfeghi, A. A.; Zhang, K.; Sadda, S.; Feuer, W.; Rosenfeld, P. J. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study Ophthalmology 2014, 121, 693-701 10.1016/j.ophtha.2013.09.044
82. Mones, J.; Yaspan, B. L.; Li, Z.; Henry, E.; Strauss, E. C. The MAHALO Phase II Results: Lampalizumab (Anti-factor D) in Patients with Geographic Atrophy, 2013.